The abstract is read at the publisher; the summary is JClub's.
Continuous glucose monitoring–derived metrics can distinguish conventionally defined prediabetes from normoglycaemia and stratify future glycaemic risk, but immediate diagnostic cut-offs are not established.
- Why it matters: Prediabetes is biologically heterogeneous and defined by episodic lab thresholds, so fasting glucose, OGTT, and HbA1c may miss temporal glycaemic variation linked to risk.
- What they did: The approach uses continuous glucose monitoring to quantify interstitial glucose patterns, while considering that device performance and sampling duration can affect sensor-derived metrics.
- The result: Incorporating a CGM phenotype into prediabetes requires reproducibility across time and devices, added clinical meaning beyond established tests and risk factors, and evidence that it changes management with a favourable benefit–harm balance.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.